News

Eli Lilly’s big-selling insulin, Humalog ... which is available in vial form or as a disposable pen. Sanofi fights back This represents Sanofi's first foray into the biosimilar diabetes market ...
The products covered include Admelog, Lantus, Toujeo, Apidra and any biosimilar of those products that Sanofi markets in the ...
Mainers who rely on insulin will now be eligible to purchase ... The products covered include Admelog, Lantus, Toujeo, Apidra and any biosimilar of those products that Sanofi markets in the ...